RECRUITING

Duobrii in Combination With Biologics

Talk to us

Conditions

Psoriasis

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

12 weeks DUOBRII to patients with 2%-10% BSA who are receiving biologic therapy for at least 24 weeks

Official Title

Open Label Study Evaluating DUOBRII in Psoriasis Patients Being Treated With Biologic Agents.

Quick Facts

Study Start:2019-10-14
Study Completion:2020-09-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04119102

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Male or female adult ≥ 18 years of age;
  2. 2. Diagnosis of chronic plaque-type
  3. 3. Psoriasis affecting 2%-10% BSA
  4. 4. Patient is being treated with biologic therapy for a minimum of 24 weeks
  5. 5. Able and willing to give written informed consent prior to performance of any study-related procedures
  1. 1. Psoriasis affecting ˂2% or \>10% BSA
  2. 2. Patient not receiving a biologic agent, or receiving biologic agent \<24weeks
  3. 3. Received treatment with any topical antipsoriatic drug product within 14 days prior to the Baseline visit.
  4. 4. Has previously used DUOBRII

Contacts and Locations

Study Contact

Jerry Bagel, MD
CONTACT
6094434500
dreamacres1@aol.com
Elise Nelson
CONTACT
6094434500
enelson@windsordermatology.com

Study Locations (Sites)

Psoriasis Treatment Center of Central New Jersey
East Windsor, New Jersey, 08520
United States

Collaborators and Investigators

Sponsor: Psoriasis Treatment Center of Central New Jersey

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2019-10-14
Study Completion Date2020-09-01

Study Record Updates

Study Start Date2019-10-14
Study Completion Date2020-09-01

Terms related to this study

Additional Relevant MeSH Terms

  • Psoriasis